Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis.
about
Nanomedicine and drug delivery strategies for treatment of inflammatory bowel diseaseIncreased susceptibility of IDH2-deficient mice to dextran sodium sulfate-induced colitis.Molecular mechanisms by which casein glycomacropeptide maintains internal homeostasis in mice with experimental ulcerative colitis.Inhibition of nuclear factor-kappaB ameliorates bowel injury and prolongs survival in a neonatal rat model of necrotizing enterocolitis.Evaluation of the effect of pyrrolidine dithiocarbamate in suppressing inflammation in mice with dextran sodium sulfate-induced colitisAnalysis of candidate colitis genes in the Gdac1 locus of mice deficient in glutathione peroxidase-1 and -2.Antisense approach to inflammatory bowel disease: prospects and challenges.The apolipoprotein E-mimetic peptide COG112 inhibits NF-kappaB signaling, proinflammatory cytokine expression, and disease activity in murine models of colitis.Differential patterns of histone acetylation in inflammatory bowel diseases.Small therapeutic molecules for the treatment of inflammatory bowel diseaseEnterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel diseaseLow molecular weight heparin relieves experimental colitis in mice by downregulating IL-1β and inhibiting syndecan-1 shedding in the intestinal mucosa.The heat shock response and cytoprotection of the intestinal epithelium.iNOS-dependent increase in colonic mucus thickness in DSS-colitic rats.Transient Receptor Potential Melastatin 2 (TRPM2) ion channel is required for innate immunity against Listeria monocytogenes.3-(3-pyridylmethylidene)-2-indolinone reduces the severity of colonic injury in a murine model of experimental colitis.Overexpression of alpha(1)-acid glycoprotein in transgenic mice leads to sensitisation to acute colitisCD4+CD29+T cells are blamed for the persistent inflammatory response in ulcerative colitis.Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis.Bone marrow-derived mesenchymal stem cell transplantation ameliorates oxidative stress and restores intestinal mucosal permeability in chemically induced colitis in mice.Peroxisome proliferator-activated receptor-γ is downregulated in ulcerative colitis and is involved in experimental colitis-associated neoplasiaGingko biloba extract (Ginaton) ameliorates dextran sulfate sodium (DSS)-induced acute experimental colitis in mice via reducing IL-6/STAT3 and IL-23/IL-17.1,25-hydroxyvitamin D relieves colitis in rats via down-regulation of toll-like receptor 9 expressionCelastrol Ameliorates Ulcerative Colitis-Related Colorectal Cancer in Mice via Suppressing Inflammatory Responses and Epithelial-Mesenchymal Transition.Pathophysiological significance of a reaction in mouse gastrointestinal tract associated with delayed-type hypersensitivity.Beneficial effect of shikonin on experimental colitis induced by dextran sulfate sodium in BALB/c miceNF-kappa B as a therapeutic target in autoimmune disease.Protective effects of ethanol extract from Portulaca oleracea L on dextran sulphate sodium-induced mice ulcerative colitis involving anti-inflammatory and antioxidant.Limited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection.Therapeutic effects of triptolide via the inhibition of IL-1β expression in a mouse model of ulcerative colitis.Protective effects of Huangqin Decoction against ulcerative colitis and associated cancer in mice.Intestinal CCL11 and eosinophilic inflammation is regulated by myeloid cell-specific RelA/p65 in mice.Selenium nanoparticles decorated with Ulva lactuca polysaccharide potentially attenuate colitis by inhibiting NF-κB mediated hyper inflammation.Overview of mouse models of inflammatory bowel disease and their use in drug discovery.5-ASA-loaded SiO2 nanoparticles-a novel drug delivery system targeting therapy on ulcerative colitis in miceAnti-inflammatory mechanism of oxymatrine in dextran sulfate sodium-induced colitis of rats.Constitutive androstane receptor regulates the intestinal mucosal response to injury.Topical antisense oligonucleotide therapy against LIX, an enterocyte-expressed CXC chemokine, reduces murine colitis.Regulation and distribution of MAdCAM-1 in endothelial cells in vitro.MicroRNA-133α regulates neurotensin-associated colonic inflammation in colonic epithelial cells and experimental colitis
P2860
Q26777400-6F1B346A-38E4-4E90-8029-3C40DC1DDF30Q33736084-228FAC4C-AE30-4D6F-B683-AE604CA66724Q33897813-0354FE6D-6CB7-4C50-9A75-A8037DF38080Q34003491-2D1DA2F6-5F0E-4585-907C-FF949C1FF23BQ34099336-5C4E71D4-A45D-4C49-B84F-D207AC2D3764Q34412323-9823BE48-3365-4921-8289-B4A0A512C8BDQ34473572-ED2BE7CB-27D3-420A-BFA3-E0B89E7030B9Q34537041-D6B0E5B0-C796-4017-BC9F-752CEA95BF9AQ34581227-DA2CD7FB-8291-4A54-81A2-AB031CA852B9Q34600992-2824339F-4910-4B9E-8451-46F0DE5BBDBBQ34827250-B3B15F2D-2654-4D60-8BD7-0BAFB7B65B2CQ34846405-2886D39F-0273-4725-A0AC-8435DF573E9FQ34966136-BFF80F63-4088-475A-951F-CFA8F70C82EDQ34972470-62A44444-C3A4-4FDF-BBD9-AD54B9E02D24Q35105165-E2BF2E3B-9DDC-44B9-A67C-1A991E822B44Q35271785-4A65A999-713D-4013-A294-32DC8EDD20B4Q35594935-58D9383E-DA0C-4A8F-84A4-AAFA13E18FE7Q35632116-EA79A24D-9A5A-44EF-8BDB-B4BAD3B71D20Q35761406-3C59DC65-7848-4ECB-BA43-4AED72F8D1EAQ35826470-9789EB33-7E2E-497A-94F7-42C09EB4DA7BQ35943219-C99926B3-E7F4-4596-A51E-098D48CA0CDFQ36411465-C41FAAC7-E462-4281-9262-C52F97862777Q36449967-FACE5602-D642-4504-8846-63C13C120363Q36458235-5714863F-BE10-468D-88F9-AA265967D518Q36496504-40E121A2-2018-4551-B1BB-8EA8AEA02F62Q36546684-363CDE5B-2967-46C7-89B0-48F25E21C031Q36709522-ACAED294-0730-493A-A935-99AFC3BCF927Q36964100-6B8FD2F5-D823-4D59-8FE4-405DB06EF0C5Q36977052-226EFDE1-320E-46D3-B412-23141C941779Q37204119-0803FA87-D156-4350-AB3B-00414D39B57AQ37641654-1EA028E5-00FF-49CC-BC51-62E3E9F70803Q37672482-1CFEC66B-183E-40DC-BC2A-452BBA8C5E19Q37686354-5662AEA2-D6A0-4D8E-A4DC-7E2F323FDAA6Q37980400-13FD37B0-B715-4764-B58B-0FF20AFCCF62Q38718705-EBAC8DD9-EC8D-42E8-95ED-BEFF6F34E1B0Q39677660-71216C00-892B-483F-8AA8-098C349115BBQ40287679-372CD0C3-2BEB-407E-9F98-F675C6AB2EB8Q40385488-CB2506E7-4A2B-4179-B2FF-F705B0AB5F59Q40781774-1B337578-6242-4F24-8A3B-20CF2CD3B31CQ40973463-9B2993C6-A7CA-4E56-AA8F-914378B620C3
P2860
Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Therapeutic effect of intracol ...... sodium (DSS)-induced colitis.
@ast
Therapeutic effect of intracol ...... sodium (DSS)-induced colitis.
@en
type
label
Therapeutic effect of intracol ...... sodium (DSS)-induced colitis.
@ast
Therapeutic effect of intracol ...... sodium (DSS)-induced colitis.
@en
prefLabel
Therapeutic effect of intracol ...... sodium (DSS)-induced colitis.
@ast
Therapeutic effect of intracol ...... sodium (DSS)-induced colitis.
@en
P2093
P2860
P1476
Therapeutic effect of intracol ...... sodium (DSS)-induced colitis.
@en
P2093
N Hamamoto
T Nishikawa
P2860
P356
10.1046/J.1365-2249.2000.01183.X
P577
2000-04-01T00:00:00Z